Literature DB >> 20023065

Increased risk of death among children with Lennox-Gastaut syndrome and infantile spasms.

Andrew R Autry1, Edwin Trevathan, Kim Van Naarden Braun, Marshalyn Yeargin-Allsopp.   

Abstract

The magnitude and causes of death among a cohort of children with epilepsy were determined. A follow-up study with a population-based cohort of 10-year-old children in the metropolitan Atlanta area with epilepsy was conducted. The National Death Index and linkage to State of Georgia death certificates were used to identify deaths. The authors estimated the expected numbers of deaths by applying mortality rates adjusted by age, race, and sex for the entire state of Georgia to the population for the follow-up period. Among the 688 children who were in the final epilepsy cohort, 64 deaths occurred; 20.6 deaths were expected (mortality ratio adjusted for age, race, and sex = 3.11). The mortality ratios for children with Lennox-Gastaut syndrome and infantile spasms were 13.92 and 11.91, respectively. Children and adolescents with epilepsy, especially those with Lennox-Gastaut syndrome or infantile spasms, have an increased risk of death.

Entities:  

Mesh:

Year:  2009        PMID: 20023065     DOI: 10.1177/0883073809348355

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  16 in total

Review 1.  Inflammation in Epileptic Encephalopathies.

Authors:  Oleksii Shandra; Solomon L Moshé; Aristea S Galanopoulou
Journal:  Adv Protein Chem Struct Biol       Date:  2017-02-28       Impact factor: 3.507

Review 2.  New avenues for anti-epileptic drug discovery and development.

Authors:  Wolfgang Löscher; Henrik Klitgaard; Roy E Twyman; Dieter Schmidt
Journal:  Nat Rev Drug Discov       Date:  2013-09-20       Impact factor: 84.694

3.  Cannabidiol Therapy for Refractory Epilepsy and Seizure Disorders.

Authors:  Victoria Golub; D Samba Reddy
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 4.  Latest American and European updates on infantile spasms.

Authors:  Andrew L Lux
Journal:  Curr Neurol Neurosci Rep       Date:  2013-03       Impact factor: 5.081

5.  Anti-seizure medications for Lennox-Gastaut syndrome.

Authors:  Francesco Brigo; Katherine Jones; Christin Eltze; Sara Matricardi
Journal:  Cochrane Database Syst Rev       Date:  2021-04-07

Review 6.  Lennox-Gastaut syndrome. Management update.

Authors:  Muradi H Al-Banji; Doaa K Zahr; Mohammed M Jan
Journal:  Neurosciences (Riyadh)       Date:  2015-07       Impact factor: 0.906

Review 7.  Comprehensive overview: efficacy, tolerability, and cost-effectiveness of clobazam in Lennox-Gastaut syndrome.

Authors:  Michele A Faulkner
Journal:  Ther Clin Risk Manag       Date:  2015-06-08       Impact factor: 2.423

Review 8.  Treatment-resistant Lennox-Gastaut syndrome: therapeutic trends, challenges and future directions.

Authors:  Adam P Ostendorf; Yu-Tze Ng
Journal:  Neuropsychiatr Dis Treat       Date:  2017-04-20       Impact factor: 2.570

9.  Premature mortality in active convulsive epilepsy in rural Kenya: causes and associated factors.

Authors:  Anthony K Ngugi; Christian Bottomley; Gregory Fegan; Eddie Chengo; Rachael Odhiambo; Evasius Bauni; Brian Neville; Immo Kleinschmidt; Josemir W Sander; Charles R Newton
Journal:  Neurology       Date:  2014-01-17       Impact factor: 9.910

10.  Long-term mortality of patients with West syndrome.

Authors:  Matti Sillanpää; Raili Riikonen; Maiju M Saarinen; Dieter Schmidt
Journal:  Epilepsia Open       Date:  2016-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.